September 18, 2019
NICE recommends Takhzyro injection as an option for preventing recurrent attacks of hereditary angioedema (HAE)
NICE has recommended the use of Takhzyro subcutaneous injection as an option for preventing recurrent attacks of hereditary angioedema (HAE) in people aged 12 and older, within their final appraisal document (FAD), Takeda UK said in a press release Wednesday.